The role of growth hormone device optimization in patient-reported outcomes: real-world evidence from South Korea

References

• Mahan JD, Warady BA. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol. 2006;21(7):917–930.
   PubMed Web of Science ®Google Scholar
• Clayton PE, Cianfarani S, Czernichow P, et al. Management of the child born small for gestational age through to adulthood: a consensus statement of the international societies of pediatric endocrinology and the growth hormone research society. J Clin Endocrinol Metab. 2007;92(3):804–810.
   PubMed Web of Science ®Google Scholar
• Deal CL, Tony M, Hoybye C, et al. GrowthHormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in prader-willi syndrome. J Clin Endocrinol Metab. 2013;98(6):E1072–E1087.
   PubMed Web of Science ®Google Scholar
• Christiansen JS, Backeljauw PF, Bidlingmaier M, et al. Growth hormone research society perspective on the development of long-acting growth hormone preparations. Eur J Endocrinol. 2016;174(6):C1–C8.
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with turner syndrome: proceedings from the 2016 cincinnati international turner syndrome meeting. Eur J Endocrinol. 2017;177(3):G1–G70.
   PubMed Web of Science ®Google Scholar
• Rosenfeld RG, Bakker B. Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract. 2008;14(2):143–154.
   PubMedGoogle Scholar
• Kapoor RR, Burke SA, Sparrow SE, et al. Monitoring of concordance in growth hormone therapy. Arch Dis Child. 2008;93(2):147–148.
   PubMed Web of Science ®Google Scholar
• Cutfield WS, Derraik JGB, Gunn AJ. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PloS One. 2011;6(1):e16223.
   PubMed Web of Science ®Google Scholar
• van Dommelen P, Koledova E, Wit JM. Effect of adherence to growth hormone treatment on 0-2 year catch-up growth in children with growth hormone deficiency. PloS One. 2018;13(10):e0206009.
   PubMed Web of Science ®Google Scholar
• Haverkamp F, Johansson L, Dumas H, et al. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice. Clin Ther. 2008;30(2):307–316.
   PubMed Web of Science ®Google Scholar
• National institute for health and clinical excellence (NICE) [internet]. NICE clinical guideline 76 (CG76). Medicines Adherence: involving patients in decisions about prescribed medicines and supporting adherence 2009 [ cited Dec 2009]. Available from: https://www.nice.org.uk/guidance/cg76/evidence/full-guideline–242062957
   Google Scholar
• Fisher BG, Acerini CL. Understanding the growth hormone therapy adherence paradigm: a systematic review. Hormone Res Paediatrics. 2013;79(4):189–196.
   PubMed Web of Science ®Google Scholar
• Norgren S. Adherence remains a challenge for patients receiving growth hormone therapy. Pediatr Endocrinol Rev. 2009;6(Suppl 4):545–548.
   PubMedGoogle Scholar
• Kremidas D, Wisniewski T, Divino VM, et al. Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers. J Pediatr Nurs. 2013;28(1):55–63.
   PubMed Web of Science ®Google Scholar
• Acerini CL, Wac K, Bang P, et al. Optimizing patient management and adherence for children receiving growth hormone. Front Endocrinol (Lausanne). 2017;8:313.
   PubMed Web of Science ®Google Scholar
• Meinhardt U, Eiholzer U, Seitz L, et al. Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay. Expert Rev Med Devices. 2014;11:31–38.
   PubMed Web of Science ®Google Scholar
• Bagnasco F, Di Iorgi N, Roveda A, et al. Prevalence and correlates of adherence in children and adolescents treated with growth hormone: A multicenter Italian study. Endocr Pract. 2017; 23(8): 929–941.
   PubMed Web of Science ®Google Scholar
• Rohrer TR, Horikawa R, Kappelgaard AM. Growth hormone delivery devices: current features and potential for enhanced treatment adherence. Expert Opin Drug Deliv. 2017;14(11):1253–1264.
   PubMed Web of Science ®Google Scholar
• Brearley C, Priestley A, Leighton-Scott J, et al. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle. BMC Clin Pharmacol. 2007;7:10.
   PubMedGoogle Scholar
• Tauber M, Payen C, Cartault A, et al. User trial of Easypod, an electronic autoinjector for growth hormone. Ann Endocrinol (Paris). 2008;69(6):511–516.
   PubMed Web of Science ®Google Scholar
• Rapaport R, Saenger P, Schmidt H, et al. Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study. Med Devices (Auckl). 2013;6:141–146.
   PubMedGoogle Scholar
• Fidotti E. A history of growth hormone injection devices. J Pediatr Endocrinol Metab. 2001;14(5):497–501.
   PubMed Web of Science ®Google Scholar
• Hokken-Koelega A, Keller A, Rakov V, et al. Patient acceptance, ease of use, and preference for Norditropin NordiFlex with NordiFlex penmate: results from an open-label, user survey of everyday use. ISRN Endocrinol. 2011;2011:803948.
   PubMedGoogle Scholar
• Tauber M, Jaquet D, Jesuran-Perelroizen M, et al. User assessment of Norditropin NordiFlex((R)), a new prefilled growth hormone pen: a Phase IV multicenter prospective study. Patient Prefer Adherence. 2013;7:455–462.
   PubMed Web of Science ®Google Scholar
• Oyarzabal M, Aliaga M, Chueca M, et al. Multicentre survey on compliance with growth hormone therapy: what can be improved? Acta Paediatr. 1998; 87(4): 387–391.
   PubMed Web of Science ®Google Scholar
• Rohrer TR, Winter F, Qvist M, et al. Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens. Expert Opin Drug Deliv. 2013;10(12):1603–1612.
   PubMed Web of Science ®Google Scholar
• De Pedro S, Murillo M, Salinas I, et al. Variability in adherence to rhGH treatment: socioeconomic causes and effect on children’s growth. Growth Horm IGF Res. 2016;26:32–35.
   PubMed Web of Science ®Google Scholar
• Leiberman E, Pilpel D, Carel CA, et al. Coping and satisfaction with growth hormone treatment among short-stature children. Horm Res. 1993;40(4):128–135.
   PubMedGoogle Scholar
• Mohseni S, Heydari Z, Qorbani M, et al. Adherence to growth hormone therapy in children and its potential barriers. J Pediatr Endocrinol Metab. 2018;31(1):13–20.
   PubMed Web of Science ®Google Scholar
• Haverkamp F, Gasteyger C. A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children. J Med Econ. 2011;14(4):448–457.
   PubMedGoogle Scholar
• Cassorla F, Cianfarani S, Haverkamp F, et al. Growth hormone and treatment outcomes: expert review of current clinical practice. Pediatr Endocrinol Rev. 2011;9(2):554–565.
   PubMedGoogle Scholar
• Graham S, Weinman J, Auyeung V. Identifying Potentially modifiable factors associated with treatment non-adherence in paediatric growth hormone deficiency: a systematic review. Hormone Res Paediatrics. 2018;90(4):221–227.
   PubMed Web of Science ®Google Scholar
• Kreitschmann-Andermahr I, Siegel S, Unger N, et al. Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients’ perspective. Pituitary. 2020;23(5):479–487.
   PubMed Web of Science ®Google Scholar
• van den Brink M, Bandell-Hoekstra EN, Abu-Saad HH. The occurrence of recall bias in pediatric headache: a comparison of questionnaire and diary data. Headache. 2001;41(1):11–20.
   PubMed Web of Science ®Google Scholar